Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany

about

Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany

Item

http://www.wikidata.org/entity/Q36214394

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Patient preferences for pallia ...... nt analysis study from Germany

@ast

Patient preferences for pallia ...... nt analysis study from Germany

@en

type

Item

label

Patient preferences for pallia ...... nt analysis study from Germany

@ast

Patient preferences for pallia ...... nt analysis study from Germany

@en

prefLabel

Patient preferences for pallia ...... nt analysis study from Germany

@ast

Patient preferences for pallia ...... nt analysis study from Germany

@en

P1476

Patient preferences for pallia ...... nt analysis study from Germany

@en

P2093

E Weidling

http://www.w3.org/2001/XMLSchema#string

J Borchardt-Wagner

http://www.w3.org/2001/XMLSchema#string

J Clouth

http://www.w3.org/2001/XMLSchema#string

M H Jen

http://www.w3.org/2001/XMLSchema#string

P Brück

http://www.w3.org/2001/XMLSchema#string

R Hofheinz

http://www.w3.org/2001/XMLSchema#string

U Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Using conjoint analysis to elicit preferences for health care

Medical management of gastric cancer: a 2014 update.

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

Patient preferences for chemotherapies used in breast cancer.

Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

P2888

s12885-016-2975-9

P304

937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-016-2975-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048990221

http://www.w3.org/2001/XMLSchema#string

P698

27923357

http://www.w3.org/2001/XMLSchema#string

P921

A' Ghearmailt

P932

5139120

http://www.w3.org/2001/XMLSchema#string